Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. medical infection
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Medical Infection Articles & Analysis

107 news found

How to prevent the spread of nosocomial infections

How to prevent the spread of nosocomial infections

Hospitals are, by definition, places of healing. Paradoxically, however, they can also be sources of infections contracted during a patient’s stay in hospital, known as nosocomial infections or healthcare-associated infections (HAIs). These infections represent a serious global public health problem, causing increased patient morbidity and mortality, prolonging hospital stays and driving up ...

ByEnvira


Why is it important to control airborne particles in a healthcare facility?

Why is it important to control airborne particles in a healthcare facility?

Not all hospital-acquired infections are transmitted by contact. A significant number of them—and often the most difficult to control—originate in the air we breathe. Pathogens responsible for diseases such as tuberculosis, legionellosis or fungal infections such as Aspergillus are spread via bioaerosols: tiny particles of biological origin that can remain suspended in the air for ...

ByEnvira


Infection Control Resources to Identify Group A Streptococcus and Other Pathogens in Puerto Rico

Infection Control Resources to Identify Group A Streptococcus and Other Pathogens in Puerto Rico

Examples of minor infections listed include impetigo, scarlet fever, and strep throat. Some of the serious infections listed by the CDC include cellulitis, necrotizing fasciitis, and streptococcal toxic shock syndrome. ...

ByCochrane & Associates, LLC


Infection Control Resources to Detect Klebsiella and Other Pathogens in Healthcare Environments

Infection Control Resources to Detect Klebsiella and Other Pathogens in Healthcare Environments

Klebsiella is described by the Centers for Disease Control and Prevention (CDC) as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. ...

ByCochrane & Associates, LLC


International Infection Prevention Week and Resources to Protect People in Puerto Rico

International Infection Prevention Week and Resources to Protect People in Puerto Rico

International Infection Prevention Week (IIPW) has been championed by the Association for Professionals in Infection Control and Epidemiology since 1986. ...

ByCochrane & Associates, LLC


CDC Report: Burkholderia multivorans Infections Linked to Hospital Ice Machines

CDC Report: Burkholderia multivorans Infections Linked to Hospital Ice Machines

A Centers for Disease Control and Prevention (CDC) report published on October 3, 2024, linked Burkholderia multivorans infections to ice machines in multiple healthcare facilities in the western United States. This post summarizes key findings, implications, and recommended practices for healthcare providers to ensure patient ...

ByLiquitech, Inc.


Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings Discussed in New Online Video

Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings Discussed in New Online Video

The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses vancomycin-resistant enterococci, commonly referred to as VRE, which are bacteria that can cause various healthcare-associated infections (HAIs). “In the CDC’s 2019 Antibiotic Resistance Threats in the United States report, VRE was ...

ByCochrane & Associates, LLC


Aspergillus Infection Risks in Hospitals, Homes and Buildings

Aspergillus Infection Risks in Hospitals, Homes and Buildings

Aspergillosis is a potentially life-threatening condition caused by a fungal pathogen known as Aspergillus. It is a common type of mold found outdoors and in indoor environments. It can be found at excessive concentrations indoors when buildings suffer water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some ...

ByCochrane & Associates, LLC


Infection Control Resources to Safeguard Patients and Building Occupants from Acinetobacter and Other Pathogens

Infection Control Resources to Safeguard Patients and Building Occupants from Acinetobacter and Other Pathogens

The Centers for Disease Control and Prevention describe Acinetobacter as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Those most at risk of infection according to the CDC include patients in hospitals, especially those who: · are ...

ByCochrane & Associates, LLC


Infection Control Resources in Puerto Rico to Identify Acinetobacter and Other Microbial Pathogens

Infection Control Resources in Puerto Rico to Identify Acinetobacter and Other Microbial Pathogens

Acinetobacter is described by the Centers for Disease Control and Prevention (CDC) as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Infections of the blood, urinary tract and lungs, or in wounds in other parts of the body can all be caused by ...

ByCochrane & Associates, LLC


Mitigating Aspergillus Infection Risks in Hospitals and Buildings across Puerto Rico

Mitigating Aspergillus Infection Risks in Hospitals and Buildings across Puerto Rico

A potentially life-threatening condition known as aspergillosis is caused by a fungal pathogen named Aspergillus. It is a common type mold that can often be found outdoors and in indoor environments that have suffered water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some species are known to be a serious ...

ByCochrane & Associates, LLC


7 December 2022 - FDA/CDC highlight need for infection preventions

7 December 2022 - FDA/CDC highlight need for infection preventions

Particular support for decolonisation of pathogens which is the approach taken by its XF-73 Nasal programme Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today reports on the publication of findings from the US Food and Drug Administration (FDA) and US Centers for ...

ByDestiny Pharma plc


XF-73 Nasal Phase 3 development plans finalised

XF-73 Nasal Phase 3 development plans finalised

A single MRSA post-surgical infection costs over $160,000 to treat and adds 15 days onto a hospital stay. ...

ByDestiny Pharma plc


Candida auris and Infection Control Resources for Healthcare Facilities in Puerto Rico

Candida auris and Infection Control Resources for Healthcare Facilities in Puerto Rico

Several years ago, the Centers for Disease Control and Prevention (CDC) announced it was establishing the Antibiotic Resistance Laboratory Network (AR Lab Network) in Puerto Rico and all 50 states. It was designed to help detect new forms of drug resistance as novel fungal threats emerge. Specifically mentioned in the announcement was Candida auris. CDC reported that this fungus poses a unique ...

ByCochrane & Associates, LLC


Successful SARS-CoV-2 trial with Ondine’s nasal photodisinfection

Successful SARS-CoV-2 trial with Ondine’s nasal photodisinfection

Clínica Universidad de Navarra has completed a randomised controlled study of Ondine Biomedical’s nasal photodisinfection technology in fully vaccinated COVID-19 patients with early symptoms of COVID-19. “Top-line results from this clinical trial suggest that nasal photodisinfection treatment rapidly and substantially suppresses SARS-CoV-2 viral replication and infectivity in ...

ByOndine Biomedical Inc


HiberGene Diagnostics introduces brand new UK division at NEQAS event

HiberGene Diagnostics introduces brand new UK division at NEQAS event

HiberGene Diagnostics, the leading manufacturer of molecular diagnostics products in Ireland, is pleased to announce that it will supply its innovative point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland. These high-quality testing solutions cover infectious and transmissible disease areas – including respiratory, sexually ...

ByHiberGene Diagnostics


WHO calls for new innovations to tackle antimicrobial resistance crisis

WHO calls for new innovations to tackle antimicrobial resistance crisis

Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi Ondine’s nonantibiotic photodisinfection technology has been proven in Canadian hospitals to kill pathogens helping to generate 84% reduction of postoperative infection rates and significant cost savings. The World ...

ByOndine Biomedical Inc


N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. ...

ByN8 Medical, LLC


Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border. ...

ByVisby Medical, Inc.


Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

The rationale for this program is based in part on published clinical evidence from Seres’ collaborators at Memorial Sloan Kettering Cancer Center showing that allogeneic HSCT patients with decreased diversity of commensal microbes are significantly more likely to die due to infection and/or lethal GvHD. SER-155 was developed using Seres’ reverse translational ...

BySeres Therapeutics, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT